Development of Orodispersible Tablets with Solid Dispersions of Fenofibrate and Co-Processed Mesoporous Silica for Improved Dissolution

被引:0
作者
Baumgartner, Ana [1 ]
Planinsek, Odon [1 ]
机构
[1] Univ Ljubljana, Fac Pharm, Askerceva 7, Ljubljana 1000, Slovenia
关键词
co-processed excipient; fenofibrate; amorphous solid dispersion; orodispersible tablets; direct compression; dissolution enhancement; DIRECT COMPRESSION; DOSAGE FORMS;
D O I
10.3390/pharmaceutics16081060
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poor water solubility is an important challenge in the development of oral patient-friendly solid dosage forms. This study aimed to prepare orodispersible tablets with solid dispersions of a poorly water-soluble drug fenofibrate and a co-processed excipient consisting of mesoporous silica and isomalt. This co-processed excipient, developed in a previous study, exhibited improved flow and compression properties compared to pure silica while maintaining a high specific surface area for drug adsorption. Rotary evaporation was used to formulate solid dispersions with different amounts of fenofibrate, which were evaluated for solid state properties and drug release. The solid dispersion with 30% fenofibrate showed no signs of crystallinity and had a significantly improved dissolution rate, making it the optimal sample for formulation or orodispersible tablets. The aim was to produce tablets with minimal amounts of additional excipients while achieving a drug release profile similar to the uncompressed solid dispersion. The compressed formulations met the requirements for orodispersible tablets in terms of disintegration time, and the drug release from best formulation approximated the profile of uncompressed solid dispersion. Future research should focus on reducing the disintegration time and tablet size to enhance patient acceptability further.
引用
收藏
页数:9
相关论文
共 29 条
[1]   Comparison of fenofibrate-mesoporous silica drug-loading processes for enhanced drug delivery [J].
Ahern, Robert J. ;
Hanrahan, John P. ;
Tobin, Joseph M. ;
Ryan, Katie B. ;
Crean, Abina M. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 (3-4) :400-409
[2]  
American Chemical Society, Common Solvents Used in Organic Chemistry: Table of Properties
[3]   Stable and Fast-Dissolving Amorphous Drug Composites Preparation via Impregnation of Neusilin® UFL2 [J].
Azad, Mohammad ;
Moreno, Jacqueline ;
Dave, Rajesh .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (01) :170-182
[4]   Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs [J].
Baghel, Shrawan ;
Cathcart, Helen ;
O'Reilly, Niall J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (09) :2527-2544
[5]  
Baumgartner A., 2024, Farm. Vestn, V75, P34
[6]   Investigating the Influence of Processing Conditions on Dissolution and Physical Stability of Solid Dispersions with Fenofibrate and Mesoporous Silica [J].
Baumgartner, Ana ;
Dobaj, Nina ;
Planinsek, Odon .
PHARMACEUTICS, 2024, 16 (05)
[7]   Effect of process parameters in high shear granulation on characteristics of a novel co-processed mesoporous silica material [J].
Baumgartner, Ana ;
Planinsek, Odon .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 188
[8]   Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery [J].
Baumgartner, Ana ;
Planinsek, Odon .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 167
[9]  
Center for Drug Evaluation and Research Guidance for Industry, 2008, Orally Disintegrating Tablets
[10]  
Council of Europe, 2019, EUROPEAN PHARMACOPOE, V10th ed.